Brief: Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million
07/05/2026 21:05
May 07 (Reuters) - Crinetics Pharmaceuticals Q1 operating expenses USD 151.112 million. Q1 basic EPS USD -1.23 Q1 operating income USD -140.378 million
Recent news on Crinetics Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million